| NCT Number | NCT07390838 |
| Lead Sponsor | Nanjing Sanhome Pharmaceutical, Co., Ltd. |
| Conditions | Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma, Breast Cancer (Locally Advanced or Metastatic), Esophageal Cancer, Gastric Cancer (GC), Solid Tumor Malignancies |
| Enrollment | 150 participants |
| Start Date | 2025-05-16 |
| Primary Completion | 2026-12-30 (estimated) |
| Study Completion | 2028-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-05 |